TrialJournal of the American Society of Nephrology : JASN2009

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Uzma F Mehdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.